These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Natural Products as Potential Leads Against Coronaviruses: Could They be Encouraging Structural Models Against SARS-CoV-2? Orhan IE; Senol Deniz FS Nat Prod Bioprospect; 2020 Aug; 10(4):171-186. PubMed ID: 32529545 [TBL] [Abstract][Full Text] [Related]
3. An Update on Promising Agents against COVID-19: Secondary Metabolites and Mechanistic Aspects. Jamshidnia M; Sewell RDE; Rafieian-Kopaei M Curr Pharm Des; 2022; 28(29):2415-2425. PubMed ID: 35899955 [TBL] [Abstract][Full Text] [Related]
4. A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV). Noor R Arch Microbiol; 2021 Jul; 203(5):1943-1951. PubMed ID: 33682075 [TBL] [Abstract][Full Text] [Related]
5. Plants-Derived Biomolecules as Potent Antiviral Phytomedicines: New Insights on Ethnobotanical Evidences against Coronaviruses. Siddiqui AJ; Danciu C; Ashraf SA; Moin A; Singh R; Alreshidi M; Patel M; Jahan S; Kumar S; Alkhinjar MIM; Badraoui R; Snoussi M; Adnan M Plants (Basel); 2020 Sep; 9(9):. PubMed ID: 32967179 [TBL] [Abstract][Full Text] [Related]
6. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Malekmohammad K; Rafieian-Kopaei M Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607 [TBL] [Abstract][Full Text] [Related]
7. Human and novel coronavirus infections in children: a review. Rajapakse N; Dixit D Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199 [TBL] [Abstract][Full Text] [Related]
8. A Mechanistic Review on Plant-derived Natural Inhibitors of Human Coronaviruses with Emphasis on SARS-COV-1 and SARS-COV-2. Guguloth SK; Lakshmi AR; Rajendran R; Rajaram K; Chinnasamy T; Huang JD; Zhang H; Senapati S; Durairajan SSK Curr Drug Targets; 2022; 23(8):818-835. PubMed ID: 34636297 [TBL] [Abstract][Full Text] [Related]
9. Structural basis of SARS-CoV-2 3CL Tahir Ul Qamar M; Alqahtani SM; Alamri MA; Chen LL J Pharm Anal; 2020 Aug; 10(4):313-319. PubMed ID: 32296570 [TBL] [Abstract][Full Text] [Related]
10. From SARS coronavirus to novel animal and human coronaviruses. To KK; Hung IF; Chan JF; Yuen KY J Thorac Dis; 2013 Aug; 5 Suppl 2(Suppl 2):S103-8. PubMed ID: 23977429 [TBL] [Abstract][Full Text] [Related]
11. Coronaviruses - a new old menace. Golke A; Piekarska K; Dzieciątkowski T Postepy Biochem; 2020 Dec; 66(4):303-308. PubMed ID: 33470077 [TBL] [Abstract][Full Text] [Related]
12. Potential Drug Strategies to Target Coronaviruses. Sarkar K; Sil PC Adv Exp Med Biol; 2021; 1352():111-124. PubMed ID: 35132597 [TBL] [Abstract][Full Text] [Related]
13. Antiviral Activity of Medicinal Plants against Human Coronavirus: a systematic scoping review of and experimentations. Namiranian P; Sadatpour O; Azimzadeh Jamalkandi S; Hossein Ayati M; Karimi M J Tradit Chin Med; 2022 Jun; 42(3):332-343. PubMed ID: 35610002 [TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig. Li Y; Wang H; Tang X; Fang S; Ma D; Du C; Wang Y; Pan H; Yao W; Zhang R; Zou X; Zheng J; Xu L; Farzan M; Zhong G J Virol; 2020 Oct; 94(22):. PubMed ID: 32847856 [TBL] [Abstract][Full Text] [Related]
15. Traditional herbal medicines to overcome stress, anxiety and improve mental health in outbreaks of human coronaviruses. Shahrajabian MH; Sun W; Soleymani A; Cheng Q Phytother Res; 2021 Mar; 35(3):1237-1247. PubMed ID: 33350538 [TBL] [Abstract][Full Text] [Related]
16. Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS. Aljabr W; Alruwaili M; Penrice-Randal R; Alrezaihi A; Harrison AJ; Ryan Y; Bentley E; Jones B; Alhatlani BY; AlShahrani D; Mahmood Z; Rickett NY; Alosaimi B; Naeem A; Alamri S; Alsran H; Hamed ME; Dong X; Assiri AM; Alrasheed AR; Hamza M; Carroll MW; Gemmell M; Darby A; Donovan-Banfield I; Stewart JP; Matthews DA; Davidson AD; Hiscox JA mSphere; 2021 Aug; 6(4):e0021921. PubMed ID: 34287009 [TBL] [Abstract][Full Text] [Related]
17. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan. Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267 [TBL] [Abstract][Full Text] [Related]
18. Recent Patents and Advances on Nanotechnologies against Coronavirus. Abedini-Nassab R; Mahdaviyan N Recent Pat Nanotechnol; 2021; 15(4):322-330. PubMed ID: 33172382 [TBL] [Abstract][Full Text] [Related]
19. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium. Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888 [TBL] [Abstract][Full Text] [Related]